33 -8 (46) 2022 — Azamkulova N.O., Irgasheva S.U. — ASSESSMENT OF CLINICAL, LABORATORY PARAMETERS, AND HEALTH STATUS OF PERIMENOPAUSAL WOMEN AFTER COVID-19

ASSESSMENT OF CLINICAL, LABORATORY PARAMETERS, AND HEALTH STATUS OF PERIMENOPAUSAL WOMEN AFTER COVID-19

Azamkulova N.O., Republican Specialized Scientific and Practical Medical Center of Obstetrics and Gynecology, Uzbekistan

Irgasheva S.U. Republican Specialized Scientific and Practical Medical Center of Obstetrics and Gynecology, Uzbekistan

Resume

The article presents the results of a survey of women who have had a coronovirus infection and are in the perimenopausal period. A total of 65 patients were examined in a comparative aspect, of which 35 had COVID-19 in moderate and severe form, 30 had not had the disease. The parameters of the climacteric syndrome, gynecological and somatic anamnesis data, clinical and laboratory parameters were assessed in dynamics. It has been established that the health status of perimenopausal women who have had a coronovirus infection is characterized by more pronounced metabolic, vegetative and psycho-emotional disorders, as well as an increase in menstrual dysfunction.    

Key words: perimenopause, climacteric syndrome, COVID-19, women’s health, menstrual function, coronavirus infection, psycho-emotional disorders.

First page

191

Last page

197

For citation: Azamkulova N.O., Irgasheva S.U. ASSESSMENT OF CLINICAL, LABORATORY PARAMETERS, AND HEALTH STATUS OF PERIMENOPAUSAL WOMEN AFTER COVID-19 //New Day in Medicine 8(46)2022 191-197 https://clck.ru/sZiyj

LIST OF REFERENCES:

1. Дикке Г.Б. Менопаузальный синдром: симптомы и механизм их возникновения — ключ к пониманию альтернатив патогенетического лечения. // РМЖ. Мать и дитя. 2019;2(1):57–64.
2. Азамкулова Н.О., Иргашева С. У., Климактерический синдром в перименопаузе после перенесенной коронавирусной инфекции, // Eurasian journal of medical and natural sciences Vol. 2 No. 6(2022)
3. Дворянский С.А., Емельянова Д.И., Яговкина Н.В. Климактерический синдром: современное состояние вопроса. // Вятский медицинский вестник. 2017;1(53):3–8.
4. Амиров Н.Б. и др. Постковидный синдром: мультисистемные «дефициты» / Н.Б. Амиров, Э.И. Давлетшина, А.Г. Васильева, Р.Г. Фатыхов // Вестник современной клинической медицины. – 2021. – Т. 14, вып. 6. – С.94-104.
5. Vehar S., Boushra M. et al. Post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’. Cleveland Clinic Journal of Medicine. 2021; 88 (5): 267-272. DOI: https://doi.org/10.3949/ccjm.88a.21010.
6. Петров В.А., Максимов М.Л., Звегинцева А.А.  Возможности флувоксамина в терапии COVID-19 и постковидного синдрома // РМЖ. №3 от 25.03.2022 стр. 34-39
7. Havervall S., Rosell A., Phillipson M. et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. // JAMA. 2021;325(19):2015–2016. DOI: 10.1001/jama.2021.5612.
8. Shanbehzadeh S., Tavahomi M., Zanjari N. et al. Physical and mental health complications post-COVID-19: Scoping review. // J Psychosom Res. 2021;147:110525. DOI: 10.1016/j.jpsychores.2021.110525.
9. Дударева В.А., Максимов М.Л., Дядикова И.Г., Звегинцева А.А., Вовк В.О., Шикалева А.А. Эндоканнабиноидная система в патогенезе ожирения. Чем помочь пациенту? От теории к практике РМЖ. Медицинское обозрение. №6 от 29.10.2020 стр. 382-389
10. Zhu L., She Z.-G., Cheng X. et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020; 31:1068–77.e3. DOI: 10.1016/j.cmet.2020.04.021.
11. Liu F., Li L., Da Xu M. et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. // J. Clin. Virol. 2020; 127: 104370. DOI: 10.1016/j.jcv.2020.104370.